Silo Pharma acquires QwikAgents software platform for 2.1M shares in off-strategy deal

Filed April 2, 2026 · Period ending March 30, 2026 · ~1 min read

Key Changes

• high

  Company acquired QwikAgents web application software and three domain names from Many Ads Inc. for 2.1 million common shares, diluting existing shareholders while preserving cash. The acquisition appears unrelated to Silo's pharmaceutical business.

  Item 1.01 verify on EDGAR →
• high

  The 2.1M share issuance was a private placement under Section 4(a)(2) exemption, meaning shares are restricted and not immediately tradable. Actual dollar value of consideration depends on stock price at July 2025 issuance date.

  Item 3.02 verify on EDGAR →
• medium

  Seller provided standard indemnification covering misrepresentations, IP infringement claims, and misconduct. This offers some protection if third parties claim ownership of the software or if undisclosed liabilities emerge.

  Item 1.01 verify on EDGAR →